Highlights d Neutrophils mediate antitumor response by sustaining an IL-12/IFNg-dependent pathway d Neutrophils are essential for unconventional ab T cell (UTCab) type 1 polarization d Type 1 UTC ab possess an innate-like phenotype and display antitumor potential in vivo d Neutrophil infiltration is associated with good prognosis in selected human tumors
In Brief
Tumor-associated neutrophils (TANs) have mainly been portrayed as tumorpromoters. Here, we describe a novel antitumor pathway in which TANs promote IL-12 production by macrophages, leading to type 1 polarization of a subset of unconventional ab T cell (UTC ab ). Type 1 UTC ab possess an innate-like phenotype and antitumor potential in vivo. In selected human tumors, neutrophil infiltration is associated with type 1 immunity and better clinical outcome.
INTRODUCTION
Neutrophils are the most abundant cell type in human peripheral blood and represent the first line of defense against invading mi-croorganisms (Kolaczkowska and Kubes, 2013) . Neutrophils play an important role in the activation and orchestration of acute inflammatory reactions (Borregaard, 2010; Ley et al., 2018) . Moreover, neutrophils have emerged as important players in the regulation of innate and adaptive immunity and in chronic inflammation (Mantovani et al., 2011; Nicolá s-Avila et al., 2017) .
Neutrophils are present in the tumor microenvironment (TME) and their function is regulated by signals produced by cancer cells and immune cells (Coffelt et al., 2016; Eruslanov et al., 2017; Ponzetta et al., 2017) . Neutrophils and the myeloid growth factor granulocyte-colony stimulating factor (G-CSF) have predominantly been associated with tumor progression (Coffelt et al., 2016; Wculek and Malanchi, 2015) . On the other hand, unleashed neutrophilic effectors have also been reported to mediate anti-cancer resistance (Colombo et al., 1991; Finisguerra et al., 2015; Fridlender et al., 2009; Granot et al., 2011; Massara et al., 2018; Sagiv et al., 2015; Singhal et al., 2016) . For instance, neutrophils have been shown to regulate the function of conventional CD4 + and CD8 + tumor-infiltrating T cells with activating or suppressive effects, thus influencing tumor growth (Mantovani et al., 2011; Nicolá s-Avila et al., 2017) . In addition to conventional T cells, neutrophils can also modulate the activation of gd T cells, regulating their interleukin (IL)-17A production in cancer (Coffelt et al., 2015) .
Available evidence on the role of neutrophils in carcinogenesis and tumor progression is essentially based on antibody-mediated cell depletion (Coffelt et al., 2015; Fridlender et al., 2009; Granot et al., 2011; Ponzetta et al., 2017) . Given the intrinsic limitations of this approach including duration, specificity, and perturbation of the system (Faget et al., 2018; Granot et al., 2011; Moses et al., 2016) , we set out to assess the role of neutrophils using a genetic strategy and a classic model of 3-methylcholanthrene (3-MCA)-induced carcinogenesis (Bonavita et al., 2015; Kaplan et al., 1998; Shankaran et al., 2001) . We took advantage of genetic deficiency of G-CSF-R, a strategy analogous to that used to dissect the role of tumor-associated macrophages (TAMs) (Lin et al., 2001) .
Unexpectedly, we found that neutrophils mediate resistance against primary carcinogenesis. Neutrophil-driven antitumor resistance was dependent on interferon-g (IFNg) produced by T cells. Neutrophil deficiency was associated with a selective impairment of type 1 polarization and IFNg production by a subset of unconventional CD4 À CD8 À ab T cells (UTC ab ). As assessed by flow cytometry and single-cell RNA sequencing (scRNA-seq) analyses, UTC ab were present in the sarcoma TME and were functionally regulated by neutrophils. Neutrophil infiltration was found to be associated with better prognosis and higher IFNG expression in human undifferentiated pleomorphic sarcomas (UPS) and in selected tumors. Thus, in murine sarcomas and selected human tumors, neutrophils are an essential component of type 1 antitumor immunity. More in general, the role of UTC ab in antitumor immunity may have been underestimated.
RESULTS

Neutrophils Mediate Resistance against Primary 3-MCA Sarcomagenesis
Genetic deficiency of the G-CSF-R (Csf3r À/À ) caused a profound neutropenia in the peripheral blood of healthy mice ( Figure S1A ) (Liu et al., 1996) . In the 3-MCA-induced sarcoma model, Csf3r À/À mice showed earlier tumor development and increased tumor growth and weight, compared to wild type mice ( Figures 1A,  1B , and S1B). The increased susceptibility of Csf3r À/À to 3-MCA carcinogenesis was consistently observed in 20 experiments conducted over a period of 4 years, although as expected for primary carcinogenesis, with variability from experiment to experiment (6 experiments are shown in Figures 1A and S1C-S1G).
Dysbiosis is known to impact on carcinogenesis and anti-tumor responses (Zitvogel et al., 2015) . However, cohousing did not affect sarcoma susceptibility ( Figure S1H ), excluding that a potential dysbiosis associated with Csf3r deficiency was involved in the observed phenotype.
In bone marrow chimeras, increased susceptibility to sarcomagenesis was associated with G-CSF-R deficiency in hematopoietic cells and neutrophil depletion by an anti-Ly6G antibody accelerated tumor development ( Figures S1I and S1J ). Adoptive transfer of bone marrow Csf3r +/+ neutrophils (purity >98.5%) ( Figure S1K ) into Csf3r À/À sarcoma-bearing mice was sufficient to completely rescue tumor growth to the level of Csf3r +/+ controls ( Figure 1C ). Collectively, these results provide unequivocal genetic evidence that neutrophils mediate protection against primary 3-MCA sarcomagenesis.
Tumor-Associated Neutrophils in Csf3r +/+ Mice Display an Activated Phenotype The number of CD45 + cells infiltrating the tumor was similar in Csf3r À/À and Csf3r +/+ mice ( Figure S2A ). Tumor-associated neutrophils (TANs) were virtually absent in Csf3r À/À tumors (Figures S2B and S2C) . In Csf3r +/+ sarcoma-bearing mice, TANs displayed an activated phenotype, characterized by increased expression of CD11b and CD54 and decreased expression of CD62L, compared to peripheral blood neutrophils . mRNA expression of pro-inflammatory genes such as Cxcl10, Il23a, Arg1, Nos2, Ccl2, Ifng, Ccl3, Met, and Il27p28 in sorted TANs was increased, compared to naive bone marrow neutrophils ( Figure S2G ). Thus, TANs presented a mixed phenotype expressing both N1-like (e.g., CD54, Ccl3, Nos2, and Met) and N2-like (e.g., Arg1 and Ccl2) markers (Finisguerra et al., 2015; Fridlender et al., 2009) .
Neutrophil Deficiency Is Associated with Altered Polarization of Tumor-Associated Macrophages
The number of TAMs was significantly increased in Csf3r À/À mice ( Figures S2B and S2C) . The increased frequency of TAMs in Csf3r À/À mice was associated with increased proliferation A B C Figure 1 . Neutrophils Mediate Resistance to 3-MCA-Induced Sarcomagenesis (A and B) Tumor (A) incidence and (B) growth of 3-MCA induced sarcomas in Csf3r +/+ and Csf3r À/À mice. (C) Tumor growth of 3-MCA-induced sarcoma in Csf3r +/+ and Csf3r À/À mice upon adoptive transfer of neutrophils (NF) in Csf3r À/À mice. 3 3 10 6 BM NF were intravenously (i.v.) transferred once a week (time points indicated by arrows) starting from the first day the tumor was palpable. Tumor growth is represented as volume over time after the first tumor observation. Data are mean ± SEM (A and B) or mean ± SD (C) . *p % 0.05, ***p % 0.001. (A and C) observed in monocytes and immature macrophages (Figure S2H) . In G-CSF-R-incompetent mice, monocytes and TAMs showed increased expression of the M2-associated marker CD206 and decreased expression of the M1-associated marker CD11c ( Figures S2I-S2K) , likely a reflection of defective type 1 immunity (see below). Gene expression analysis on sorted TAMs confirmed the increased expression of M2-like-related genes (Murray et al., 2014) , including Chil3, Tgfb1, and Msr1, in Csf3r À/À -derived TAMs, while the expression of M1-related genes was either not modulated or decreased ( Figure S2L ). Intratumor vessel density was not altered in Csf3r À/À mice ( Figures  S2M and S2N ). The G-CSF-R is expressed by monocytic lineage cells, although to a much lower extent compared to neutrophils (Christopher et al., 2011) . However, G-CSF did not affect macrophage polarization by classical M1 or M2 signals (IFNg and IL-4), and if anything, it skewed these cells in an M2-like direction ( Figures  S2O-S2R) .
Therefore, the M2-like phenotype found in Csf3r À/À TAMs is due to the absence of neutrophil-dependent response and not to lack of G-CSF-R signaling in the monocytic lineage.
Neutrophils and Macrophages Cooperate to Promote an IFNg-Dependent Antitumor Response
Macrophages obtained during 3-MCA carcinogenesis in G-CSF-R-competent mice expressed IL-12 and those from Csf3r À/À mice displayed reduced Il12a and Il12b mRNA expression (Figure 2A) . These results raised the issue of the role of TAMs in the increased susceptibility of Csf3r À/À mice to 3-MCA carcinogenesis. As shown in Figures S2S and S2T , TAM depletion using an anti-CSF-1R (CD115) monoclonal antibody (mAb) did not rescue the phenotype of G-CSF-R-deficient mice, consistently with an essential role of neutrophils. Interestingly, TAM depletion increased carcinogenesis in G-CSF-R competent mice (Figure S2T) and drastically reduced the tissue levels of . As shown in Figures 2B-2E and  Table S1 , the increased sarcoma development observed in Csf3r À/À neutrophil-deficient mice was associated with lower levels of IL-12p70 and IFNg. Neutrophil adoptive transfer restored the expression of IL-12p70 and IFNg in the TME of sarcoma-bearing Csf3r À/À mice (Figures 2D and 2E) . In vivo neutralization of IFNg caused a dramatic increase of tumor incidence in Csf3r +/+ mice as previously reported (Kaplan et al., 1998 (B) and IL-12p70 (C) concentrations at the 3-MCA injection site (10 days after 3-MCA administration) after treatment with anti-CD115 antibody or isotype control. (D and E) IFNg (D) and IL-12p70 (E) concentrations in tumor homogenates after adoptive transfer of 3 3 10 6 neutrophils once a week starting from the first day the tumor was palpable. (D) and (E) are two independent experiments conducted 12 months apart. (F) Incidence of 3-MCA induced sarcomas in Csf3r +/+ and Csf3r À/À mice treated with anti-iFNg antibody or with isotype control. Figure S2 and Table S1 . et al., 2007; Shankaran et al., 2001) , but not in Csf3r À/À mice (Figure 2F) , abolishing the difference in sarcoma susceptibility between Csf3r +/+ and Csf3r À/À control mice. These results indicate that the protective effect exerted by neutrophils was dependent on type 1 immunity and on the production of IFNg.
Neutrophils Are Essential for Type 1 Polarization of Unconventional ab T Cells
Having established that IFNg played a key role in neutrophilmediated resistance to 3-MCA carcinogenesis, it was important to identify the cellular source of this cytokine. Analysis of Ifng mRNA indicated T cells as the major source of this cytokine in the TME ( Figure S3A) . No difference was observed in IFNg production in CD4 + , CD8 + , and gd T cells between Csf3r +/+ and Csf3r À/À mice ( Figure 3A) . In contrast, the frequency of IFNg + CD4 À CD8 À unconventional ab T cells (UTC ab ) was drastically reduced (by 61.3% ± 11.4%; mean ± SEM in 2 experiments) in Csf3r À/À tumors ( Figure 3A ). We then assessed the polarization of tumor-infiltrating CD3 + T cell subsets by flow cytometry (gating strategy in Figure S3B ). UTC ab from Csf3r À/À tumors displayed reduced expression of T-bet and Eomes and increased expression of Rorgt, indicating a skewing toward a type 3 activation state ( Figures 3B and 3C) . A trend toward a skewed UTC ab polarization was also observed in the spleen of Csf3r À/À tumor-bearing mice, although to a minor degree compared to sarcoma-infiltrating cells ( Figure S3C ). gd T cells from Csf3r À/À sarcomas showed increased Rorgt expression, while Eomes and T-bet expression was not altered in this cell type (Figure S3D) . Minor or no differences were observed in conventional CD4 + T cells and CD8 + T cells ( Figure S3D ). Neutrophil adoptive transfer reversed to a significant extent the polarization defect observed in UTC ab from Csf3r À/À tumors ( Figure 3D ). Increased T-bet expression was also observed in gd T cells and CD8 + T cells ( Figure S3E ). IL-17A expression was significantly increased in Csf3r À/À UTC ab and gd T cells, in agreement with their increased expression of Rorgt ( Figure S3F ). Natural killer (NK) cells are known to be important IFNg producers (Vivier et al., 2018) and have been shown to undergo a functional conversion toward ILC1 during sarcoma progression (Gao et al., 2017 ), but no difference was observed in abundance or maturation state of the NK cell compartment in Csf3r À/À tumors (Figures S3G and S3H) . Previous reports indicated that innate-like gd T lymphocytes, represented an early source of IFNg during the 3-MCA-induced sarcomagenesis (Gao et al., 2003) . Here, the impaired type 1 activation state of UTC ab was observed as early as 10 days after and T-bet expression in UTC ab from Csf3r +/+ and Csf3r À/À tumors. (C and D) Quantification of Eomes, Rorgt, and T-bet expression in UTC ab from Csf3r +/+ and Csf3r À/À tumors (C) and in Csf3r À/À mice after adoptive transfer of neutrophils (D) . (E) Expression of Eomes, Rorgt, and T-bet in UTC ab infiltrating the 3-MCA injection site (10 days after administration of 3-MCA).
(F) Quantification of iNKT, MAIT, and DNT ab frequencies among sarcoma-infiltrating CD45 + cells. (G) Polarization of tumor-associated DNT ab cells after neutrophil adoptive transfer. (D and G) 3 3 10 6 neutrophils were transferred i.v. once a week starting from the first day the tumor was palpable. (E) 3 3 10 6 neutrophils were transferred i.v. at days À1, 0, 1, and 9 with respect to 3-MCA administration. (A and C-G) 3-MCA injection, while little or no differences were observed in the polarization of gd and CD4 + T cells ( Figures 3E and S3I ). The frequency of UTC ab , gd T cells, and conventional CD4 + T cells was not appreciably altered at the 3-MCA injection site ( Figure S3J ). It should be noted that at early times (10 days after 3-MCA injection), CD8 + T cells were virtually absent ( Figure S3J ). Bone marrow neutrophil transfer induced a complete rescue of T-bet expression and partially reduced the expression of Rorgt in Csf3r À/À UTC ab present at the 3-MCA injection site, as early as 10 days after 3-MCA administration, indicating that neutrophils are an essential component of UTC ab polarization early in 3-MCA-induced sarcomagenesis ( Figure 3E ). In contrast, the polarization of other T cell subsets was not affected by neutrophil transfer at early time points ( Figure S3I ). Csf3r À/À UTC ab expressed high levels of Plzf ( Figures S4A and  S4B ), a commonly expressed transcription factor in invariant natural killer T (iNKT) cells and mucosal-associated invariant T (MAIT) cells (Koay et al., 2016; Kovalovsky et al., 2008) . These innate-like T cell subsets are also prevalently negative for CD4 and CD8 and can express Rorgt and T-bet (Cui et al., 2015; Engel et al., 2016; Rahimpour et al., 2015) . Dissection of intratumor UTC ab into MAIT, iNKT, and a third cell subset, referred to as ab double negative T (DNT ab ) cells, showed the heterogeneity of UTC ab in 3-MCA-treated mice (Figures S4C and S4D) . We found increased frequencies of iNKT, MAIT, and DNT ab cells in Csf3r À/À sarcomas, but only the polarization of DNT ab cells was altered in neutropenic mice ( Figures 3F, 3G , S4E, and S4F). In the same line, neutrophil adoptive transfer modulated the polarization of DNT ab cells but not iNKT and MAIT cells both at the early time point (at the 3-MCA injection site, day 10) (Figures S4G-S4I) and in established tumors ( Figures 3G, S4E , and S4F). On day 10, the frequency of UTC ab subsets was unaffected in Csf3r À/À mice ( Figure S4J ). The presence and polarization of UTC ab subsets were not altered in the subcutaneous tissue of healthy mice ( Figures S4K-S4N ). Altogether, these data showed that neutrophils specifically regulated the polarization of DNT ab cells at early and late time points during carcinogenesis.
Neutrophil-Dependent IL-12 Production Is Essential for IFNg Expression in UTC ab
In an effort to better characterize the features of UTC ab associated with neutrophil-sustained anti-sarcoma type 1 immunity, bulk RNA-seq analysis of sorted sarcoma-infiltrating UTC ab was performed. 95 genes were differentially expressed between Csf3r +/+ and Csf3r À/À UTC ab ( Figure 4A ; Table S2 ). The expression of Il17a, Tbx21, Eomes, and Ifng genes in Csf3r À/À UTC ab was in line with data obtained by flow cytometry at the protein level with decreased expression of T-bet, Eomes, and IFNg and increased expression of IL-17A ( Figures 3A-3C and S3F). Ingenuity pathway analysis (IPA) highlighted the upregulation of pathways involved in inflammatory responses and neutrophil recruitment and downregulation of the pathway of Th1 immune response in Csf3r À/À UTC ab ( Figure S5A ; Table S3 ). To identify the signaling pathways specifically activated on cancer-associated UTC ab , we compared the transcriptome of tumor-associated Csf3r +/+ UTC ab with gd T cells and conventional CD4 + and CD8 + T cells and found 190 differentially expressed genes (Figure S5B ; Table S2 ). The Ifng mRNA levels detected in UTC ab isolated from Csf3r +/+ sarcomas were comparable to that expressed by CD8 + and gd T cells ( Figure S5C ), indicating the significance of UTC ab -derived IFNg in the TME.
Upstream regulator analysis predicted the increased activation of STAT4, IL-18, and IL-12 pathways in tumor-associated UTC ab , compared to other T cell subsets ( Figure S5D ; Table S3 ). qPCR performed on splenic T cell subsets from untreated mice confirmed the higher expression of Il12rb1, Il12rb2, Il1r5, and Il1r7 in UTC ab compared to conventional T cells (Figures 4B and 4C) . Accordingly, UTC ab produced higher IFNg levels in response to IL-12 plus IL-18 stimulation, compared to other T cell subsets ( Figure 4D ). In vivo IL-12p70 neutralization skewed the polarization of Csf3r +/+ UTC ab to a T-bet low phenotype ( Figure 4E ), while no effect was observed in gd T cells ( Figure S5E ). Consistently, signaling related to several type 1 cytokines in Csf3r À/À UTC ab , including IL-12, were predicted to be significantly inhibited compared to Csf3r +/+ UTC ab ( Figure 4F ; Table S3 ).
The results discussed above suggest that in 3-MCA carcinogenesis neutrophils, in concert with macrophages, trigger a protective type 1 response involving IFNg-producing UTC ab cells. In an effort to explore the cellular basis for this tripartite interaction, an in vitro coculture system was set up. For these studies, spleen-isolated UTC ab, which are composed by more than 85% of DNT ab cells, were used ( Figure S5F ). In an in vitro coculture model, neutrophils dramatically amplified IL-12 production by macrophages in response to triggering by cytokines and TLR9 agonist ( Figure 4G ) or, to a lesser extent, STING agonist ( Figure S5G ), which mimic conditions of tissue damage and remodeling. Neutrophil-mediated amplification was contactdependent ( Figure 4G ). The amount of IL-12 produced in this experimental setting was sufficient to trigger IFNg production by UTC ab but not by CD4 + and CD8 + conventional T cell populations isolated from the spleen of untreated control mice (Figure 4H) . Importantly, upon exposure to relevant cytokines, sarcoma-infiltrating DNT ab cells are the most potent producers of IFNg compared to other T cell subsets ( Figure 4I ). Collectively, these data suggest that the neutrophil-mediated maintenance of UTC ab type 1 polarization is driven by their higher sensitivity to IL-12 compared with other T cell populations.
Single-Cell RNA-Seq Analysis of Tumor-Infiltrating UTC ab
To dissect the diversity of tumor-associated UTC ab subsets, scRNA-seq was performed on sorted sarcoma-infiltrating UTC ab, isolated from Csf3r +/+ (14,721 cells) and Csf3r À/À (16,902 cells) tumors. scRNA-seq analysis revealed the transcriptional complexity of the UTC ab population. Unsupervised clustering using Seurat methodology (Butler et al., 2018) allowed the identification of 12 clusters ( Figures 5A and 5B ).
Each cluster was characterized by a specific gene signature, associated to distinct effector functions, biological processes, and activation states (Figures 5A and 5C; Table S4 ). Clusters 1-4 represented more than 75% of total UTC ab and were differentially enriched in Csf3r +/+ and Csf3r À/À sarcomas (Figures 5A and 5B) . In particular, clusters 1 and 3 were enriched in Csf3r À/À sarcomas (Figures 5A and 5B) Table S4 ) and with the type 3 polarization state of Rorgt + DNT ab cells (i.e., Tmem176a-b, Il17a, Rorc) ( Figures 5C and 5D ). On the other hand, clusters 2 and 4 were enriched in Csf3r +/+ sarcomas ( Figures 5A and 5B ) and presented high expression of effector molecules (i.e., Gzmb, Ifng, Tbx21) compatible with the type 1 activation state of T-bet + DNT ab cells and genes related to Ly49 family (Klra1, Klra7, Klra9) ( Figures 5C and 5D ). The relative frequencies of cell subtypes obtained through flow cytometric analysis indicated a complete quantitative overlap of Rorgt + DNT ab cells with cluster 1, MAIT cells with cluster 3, and T-bet + DNT ab cells with clusters 2 and 4 ( Figures S5H-S5J ). Cluster 5 displayed a gene signature Tables S2 and S3. related to iNKT cells (Table S4 ), in line with quantitative data from flow cytometry analysis ( Figure S5K ). No expression of Csf3r was detected in any Csf3r +/+ UTC ab subset, thus excluding that lack of G-CSF-R signaling in UTC ab cells might impact on their polarization and function (data not shown).
Correlation analysis performed on the whole transcriptome highlighted the existence of two main functionally distinct cluster groups ( Figure S6A ), which mirrored the respective composition of UTC ab subsets in Csf3r +/+ and Csf3r À/À sarcomas. Gene set variation analysis (GSVA) performed on differentially expressed genes for each cluster showed the enrichment of IFNg signaling and IL-12 signaling mediated by STAT4 in clusters enriched in Csf3r +/+ sarcomas (clusters 2 and 4) ( Figure S6B ), in line with data obtained by flow cytometry (Figure 3 ). Accordingly, Il12rb2 expression was mainly confined to clusters 2 and 4 ( Figure 5D ), confirming their higher sensitivity to IL-12. These clusters were also characterized by enrichment in gene signatures associated with innate-like T cell activation and cytotoxic activity (e.g., DAP12 signaling, TRAIL signaling, FasL signaling, and T cytotoxic pathways) ( Figure S6B ).
To better characterize the 12 identified UTC ab clusters and their functional heterogeneity, we analyzed the gene expression of molecules related to key biological pathways. In particular, we assessed the enrichment of genes related to cell proliferation (Li et al., 2019) (Figure S6C Figure S6C ). Clusters 1 and 3 were characterized by the expression of a specific set of immune checkpoints (i.e., Icos, Sigirr, and Vsir) and chemokine receptors (i.e., Cxcr6, Ccr1, and Ccr4). On the other hand, clusters 2 and 4 expressed several effector molecules (i.e., Gzmb, Gzmd, and Prf1) and a different set of chemokine receptors and costimulatory molecules, including Cxcr3, Ccrl2, and Cd28 (Figures S6D-S6F). Among the other UTC ab subsets, cluster 12 expressed genes related to functionally active, terminally differentiated T cells (i.e., Gzmk, Gzma, S1pr5, Cx3cr1, and Pdcd1) (Figures S6D-S6F), while cluster 9 was characterized by the expression of migratory molecules typical of naive T cells such as S1pr1, Ccr7, and Sell ( Figure S6D ). Importantly, clusters 2 and 4 showed a specific enrichment of NK cell-related genes, in particular those included in the Ly49 (Klra) and NKG2 (Klrc) receptor families ( Figure 5E ). We validated these findings by flow cytometry on sarcoma-infiltrating Csf3r +/+ T cells ( Figures 5F and 5G) .
Indeed, tumor-associated DNT ab cells displayed a unique set of Ly49 molecules (Figures 5F and 5G) and expressed higher levels of CD94 and NKG2ACE compared to any other T cell subset ( Figures 5F and 5G) .
A Monocle-guided transcriptional trajectory identified five different functional states ordered along an artificial pseudotime, in which the 12 UTC ab clusters were differentially distributed (Figures 6A and 6B) . The trajectory was defined by a gene set that included molecules related to T cell polarization (i.e., Tbx21 and Rorc), effector functions (i.e., Gzmb, Ifng, and Il17a), and activation state (i.e., Nr4a1,3) ( Figure S6G ; Table S5 ). Interestingly, type 3 polarized cells (clusters 1 and 3) and type 1 polarized cells (clusters 2 and 4) were positioned at the opposite ends of the trajectory and represent the extremes in a spectrum of functional states (Figures 6A and S6G; Table S5 ). Importantly, the expression of several Klra genes was dynamically regulated during the trajectory and was higher in state 5 ( Figures 6C and S6G ). A previously validated splenic NK cell gene signature (Crinier et al., 2018) was significantly enriched in cells pertaining to state 5 (clusters 2 and 4), thus confirming their innate-like phenotype ( Figure 6D ). Notably, splenic DNT ab cells from untreated mice showed an array of receptors analogous to that observed in tumor-infiltrating DNT ab cells ( Figures 6E and 6F ), suggesting that the spleen might represent a Ly49 + DNT ab cell reservoir. Thus, these results provide insight into the diversity of tumorassociated UTC ab at a single-cell level and highlight a subset of Ly49R-expressing UTC ab (i.e., DNT ab in clusters 2 and 4) with type 1 polarization and potential antitumor activity.
In an effort to obtain an indication as to the actual antitumor potential of DNT ab cells, we conducted an in vivo cotransfer model in two transplantable murine sarcoma models (MN-MCA1 and FS6) (Bonavita et al., 2015) . At low DNT ab /tumor cell ratios (1:5 and 1:20), DNT ab cells significantly reduced tumor growth ( Figure 6G and 6H). Thus, DNT ab cells can indeed mediate antitumor resistance in vivo.
Neutrophil Infiltration Is Associated with Better Prognosis and Type 1 Immunity in Selected Human Tumors
The results reported above identify a novel neutrophil-orchestrated pathway of effective type 1 immunity against sarcomagenesis. It was therefore important to explore its significance in Table S4. human disease. Human soft tissue sarcomas (STS) are a heterogeneous and complex set of neoplasias in terms of genetic abnormalities and clinical behavior, responsible for $5,000 deaths per year in the United States (American Cancer Society, 2017; Taylor et al., 2011) . We interrogated the RNA-seq The Cancer Genome Atlas (TCGA) database and found that in undifferentiated UPS a type 1 immune response gene signature and IFN, were associated with favorable outcome (Figures 7A and 7B ; Table S6 ). Moreover, CSF3R expression was also associated with better outcome in terms of overall survival in UPS patients ( Figure 7C ). Using a previously validated neutrophil-specific gene signature (Bindea et al., 2013; Chao et al., 2016) (31 genes, listed in Table S6 ), UPS patients were divided into TAN high and TAN low subgroups. The resulting Kaplan-Meier curve showed that patients with TAN high tumor biopsies at diagnosis had a significant survival advantage compared to TAN low patients and a trend was observed for recurrence-free survival (hazard ratio [HR] 0.28; 95% confidence interval [CI] 0.07-1.16) (Figures 7D and S7A) . Interestingly, high CSF3R expression was associated with a type 1 immunity signature and with IFNG expression (Figures 7E and 7F) . No association was observed between CSF3R, neutrophil signature, IFNG, or type 1 immune signature and outcome in other sarcomas (i.e., dedifferentiated liposarcoma, leiomyosarcoma and myxofibrosarcoma) ( Figures S7B-S7M ). TAN infiltration in human UPS tumor specimens was validated by immunohistochemistry for CD66b in a separate cohort of 19 UPS patients followed at Humanitas Clinical and Research Center ( Figure 7G ; Table S7 ). The mean number of neutrophil infiltration ranged from 1 to 17 cells per field ( Figure 7G ). Recurrence-free survival was higher in CD66b high UPS patients (Figure 7H) . Interestingly UPS, which accounts for 14% of total STS (Brennan et al., 2014) , has been suggested to be the counterpart of 3-MCA-induced sarcomas (Katenkamp et al., 1988; Li et al., 2010) .
We extended our analysis to other human cancer datasets and found a significantly positive correlation between the neutrophilic infiltrate, IFNG expression, a type 1 immune response gene signature and better prognosis in colorectal cancer (CRC) ( Figures 7I-7L ). Moreover, CSF3R was positively correlated with IFNG expression ( Figure 7M ), suggesting that the neutrophil-IFNg axis might be relevant in selected human tumors. Interestingly, high neutrophil infiltration assessed by immunohistochemistry has previously been associated with better outcome in CRC in five independent reports (Berry et al., 2017; Bindea et al., 2013; Galdiero et al., 2016; Governa et al., 2017; Wikberg et al., 2017) . These results suggest that, mirroring findings in 3-MCA carcinogenesis, a neutrophil-type 1 immunity axis may play a role in resistance against selected human tumors ( Figures  7 and S7N-S7W ), in particular UPS and CRC.
DISCUSSION
Evidence based on antibody-mediated depletion and on clinical associations suggests that neutrophils can exert a dual influence on carcinogenesis, progression to metastasis and response to therapy (Coffelt et al., 2016; Engblom et al., 2017; Fridlender et al., 2009; Galdiero et al., 2016; Granot et al., 2011; Massara et al., 2018; Wculek and Malanchi, 2015) . Here, we provide unequivocal genetic evidence based on Csf3r deficiency, supported by antibody-dependent depletion and adoptive cell transfer, that neutrophils are essential for mounting an effective type 1 IFNg-dependent immune response, which restrains 3-MCA sarcomagenesis.
T cells and IFNg have long been known to mediate resistance against 3-MCA-driven carcinogenesis (Kaplan et al., 1998; Koebel et al., 2007; Shankaran et al., 2001) . Here, we report that neutrophil deficiency was associated with a selective functional skewing of UTC ab cells with no discernable impact on the polarization state of other T cell subsets. It remains unclear whether the enhanced carcinogenesis observed in Csf3r À/À neutrophildeficient mice is only a reflection of defective IFNg production, increased skewing to a type 3 IL-17 response, or a combination of the two. The discovery of a neutrophil/UTC ab axis, relevant to the control of mesenchymal carcinogenesis, raises the general issue of the relevance of innate-like UTC ab cells in cancer.
The neutrophil-dependent pathway of resistance to sarcoma induction by 3-MCA involved IL-12 produced by macrophages. In an in vitro coculture model, neutrophils dramatically amplified macrophage-derived IL-12 release, which was sufficient to trigger IFNg production by UTC ab but not by CD4 + or CD8 + T cells. This finding is reminiscent of a previously reported innate lymphoid cell subset, characterized by a unique capacity to produce IFNg in response to IL-12 (Fuchs et al., 2013) . Thus, in 3-MCA sarcomagenesis a tripartite interaction involving neutrophils, macrophages, and UTC ab is an essential component of type 1 immune resistance. (A) . Bar graphs represent the frequency of cells belonging to each cluster in the five states. Clusters are ordered according to their calculated pseudotime mean score (from low to high pseudotime). (C) Representation of Klra gene expression plotted as a function of pseudotime. (D) Violin plots showing the enrichment of a splenic NK cell gene signature described in (Crinier et al., 2018) in the five transcriptional states identified by Monocle analysis. Mean Z score was calculated for each cell. Statistical significance was calculated comparing state 5 with every other state. (E) Expression of NK cell-related molecules on splenic Csf3r +/+ T cell subsets isolated from untreated mice, assessed by flow cytometry. (F) Representative histograms of the analysis shown in (D) . (G and H) In vivo cotransfer assay was performed with sorted DNT ab cotransferred with two sarcoma cell lines. 10 5 DNT ab were co-injected (subcutaneously [s.c.]) with either 2 3 10 6 FS6 cells (G) or 5 3 10 5 MN-MCA1 cells (H) . scRNA-seq analysis showed that tumor infiltrating UTC ab were highly heterogeneous. Twelve clusters were identified, and four of them represented over 75% of the total UTC ab pool. These clusters included cells with molecular signatures of MAIT cells. Csf3r deficiency was associated with selective depletion of DNT ab cells belonging to clusters 2 and 4, characterized by a gene expression repertoire indicative of antitumor effector function. These cells expressed several NK cell-related molecules, such as Ly49 inhibitory receptors as well as CD94/NKG2A inhibitory complex. Ly49 + DNT ab cells were present in the spleen of untreated mice and were able to mediate antitumor activity in vivo suggesting that the spleen might represent a reservoir of Ly49 + DNT ab cells endowed with antitumor potential. Interestingly, the targets of current checkpoint blockade therapies PD-1 and CTLA-4 were not prominently expressed by these cells. Thus, the present results suggest that in tumors in which there is evidence for a neutrophil/IFNg resistance pathway, targeting DNT ab cell inhibitory receptors should be considered as an alternative or complementary strategy. These results highlight for the first time the presence, diversity, and antitumor potential of UTC ab in the TME and suggest that neutrophils can sustain the antitumor potential of Ly49 + DNT ab cells.
A type 1 immune response signature, IFNG, CSF3R, and a neutrophil signature were associated with better survival in selected human tumors, including UPS and CRC (Figures 7  and S7N-S7W ). The finding of neutrophil infiltration being associated with better outcome based on in silico analyses of public databases was consistent with data obtained by immunohistochemistry for UPS in the present report ( Figures 7G and 7H ) and for CRC in five independent previous studies with large case lists (Berry et al., 2017; Bindea et al., 2013; Galdiero et al., 2016; Governa et al., 2017; Wikberg et al., 2017) . These results strongly suggest that the neutrophil-dependent pathway of antitumor resistance described in 3-MCA carcinogenesis is indeed relevant in selected human tumors. This neutrophil-type 1 immunity axis may have broader significance in neoplastic and non-neoplastic conditions.
The results reported here emphasize the diversity of mechanisms of immune resistance in human tumors, even when histo-logically related, and call for tailoring of immunotherapy strategies and correlate biomarkers, including neutrophil-related ones, to the diversity of immune pathways. Moreover, the occurrence and significance of UTC ab in the TME may have been underestimated.
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: Figure S7 and Tables S6 and S7 
CONTACT FOR REAGENT AND RESOURCE SHARING
Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Alberto Mantovani (alberto.mantovani@humanitasresearch.it) or to Sebastien Jaillon (sebastien.jaillon@humanitasresearch.it).
EXPERIMENTAL MODEL AND SUBJECT DETAILS Animals
All mice used were on a C57BL/6J genetic background. Csf3r-deficient mice were purchased from the Jackson Laboratory, Bar Harbour, Maine, US. All colonies were housed and bred in the SPF animal facility of Humanitas Clinical and Research Center in individually ventilated cages. Mice were randomized based on age and weight. Procedures involving animals handling and care were conformed to protocols approved by the Humanitas Clinical and Research Center (Rozzano, Milan, Italy) in compliance with national (D.L. N.116, G.U., suppl. 40, 18-2-1992 Carcinogen-induced sarcoma model Male mice were injected s.c. with a single dose of 100 mg of 3-MCA (Sigma-Aldrich, St Louis, US) dissolved in corn oil and assessed for tumor development over the course of 5 months. Data are shown as tumor incidence and tumor volume according to the formula: Volume = (Dxd 2 )/2, where D = larger tumor diameter and d = smaller tumor diameter, during the entire duration of the experiment using a calliper. In neutrophil adoptive transfer experiments, tumor growth is expressed over time (days) after the first palpable tumor observation (V = 4 mm 3 ). In cohousing experiments, Csf3r +/+ and Csf3r À/À male mice were cohoused in a 1:1 ratio from birth until 8 weeks of age, and then injected with 3-MCA.
Depletion and blocking experiments
For neutrophil and IFNg depletions, mice were intraperitoneally (i.p.) treated with 200 mg of specific mAbs (Rat anti-Ly6G, Clone 1A8; Rat Isotype Control Clone 2A3; Rat anti-iFNg, Clone XMG1.2; Rat Isotype Control, Clone HRPN) on the day before 3-MCA administration, and with 100 mg twice a week for the entire duration of the experiment. In IL-12p75 depletion experiments, mice were i.p. treated with 1 mg of Rat anti-iL-12p75 (Clone R2-9A5; Rat Isotype Control, Clone LTF-2) on the day before 3-MCA administration, and with 500 mg on days +1 and +6 after 3-MCA administration. For M-CSFR blockade experiments mice were i.p. treated as previously shown (Hashimoto et al., 2011) with 1.5 mg of Rat anti-CD115 (Clone AFS98; Rat Isotype Control, Clone 2A3) on the day before 3-MCA administration, and with 300 mg twice a week after 3-MCA administration until mice reached experimental endpoint. In a second set of experiment, mice were i.p. treated with 1.5 mg on the day before 3-MCA administration and with 300 mg on days 0, +3 and +7 after 3-MCA administration. All depleting antibodies were purchased from Bioxcell (West Lebanon, US).
Neutrophil adoptive transfer
In a first set of experiments, 3x10 6 MACS-enriched bone marrow neutrophils (Purity R 97.5%) isolated from naive Csf3r +/+ mice were injected i.v. in Csf3r À/À sarcoma-bearing mice, once a week, starting from the first visible observation of tumor occurrence (range 75-100 days after 3-MCA administration), until mice reached the experimental endpoint. In a second set of experiments, neutrophils were injected in Csf3r À/À mice on day À1, 0, 1 and 9 with respect to 3-MCA administration, and mice were sacrificed on day 10.
Generation of Bone Marrow Chimeras
Csf3r-competent and -deficient mice were lethally irradiated with a total dose of 900 cGy. 2 hours later mice were injected in the retroorbital plexus with 4x10 6 nucleated bone marrow cells obtained by flushing of the cavity of a freshly dissected femur from wild-type or Csf3r-deficient donors. Recipient mice received gentamycin (0.8 mg/ml in drinking water) starting 10 days before irradiation and maintained during 2 weeks. 8 weeks after bone marrow transplantation, mice were challenged with 3-MCA.
Sarcoma transplantable models FS6 and MN-MCA1 cell lines were cultured in RPMI-1640 medium supplemented with 10% Fetal Bovine Serum (FBS) 1% L-Glutammine, 1% Pen/Strept. On the day of the experiment cells were detached with Tripsin/EDTA solution (Lonza, Basel, Switzerland), washed twice in PBS À/À and diluted in PBS À/À before injection. Mice were anesthetized and shaved on the back, 2x10 6 FS6 or 5x10 5 MN-MCA1 were injected subcutaneously. In the in vivo cotransfer experiments cells were co-injected with FACS-sorted 1x10 5 DNT ab cells isolated from spleen of healthy Csf3r +/+ mice.
Undifferentiated pleomorphic sarcoma patients
Patients (n = 19) whose biological samples were included in the study gave their signed consent to donate the tissue remaining after the diagnostic procedure. Human UPS surgical samples were collected from Humanitas Biobank (n = 19), upon approval by the Humanitas Research Hospital Ethical Committee (authorization 609/17, issued on 18 December 2017). Informed consent was obtained from all participants. Demographics and clinicopathologic features of recruited patients are described in Table S7 .
METHOD DETAILS
Organ collection, digestion and flow cytometry analysis
Single-cell suspensions of sarcomas, blood, spleen and skin were obtained and stained. Sarcomas were manually disaggregated and incubated with 0.1 mg/mL Type IV Collagenase (Sigma Aldrich) in PBS À/À at 37 C for 60 minutes. Cell suspensions from spleen were obtained as previously described (Ponzetta et al., 2015) . Dorsal skin samples from untreated mice and 3-MCA injection sites were manually disaggregated and incubated with 0.35 mg/mL DNase (Roche, Basel, Switzerland) and 0.125 mg/mL Liberase TM (Roche) in RPMI at 37 C for 90 minutes. Before further procedures, cell suspensions from every organ were filtered using 70 mm cell strainers (Corning, Corning, US). Extracellular staining was performed using a PBS À/À buffer containing FCS 2%, EDTA 2mM and NaN 3 0.05%. Prior to any surface staining, cells were incubated with Aqua LIVE/Dead-405 nm staining (Invitrogen, Carlsbad, US) or Live/Dead Fixable Dye eF780 (ThermoFisher, Waltham, US) and negative cells were considered viable. Then Fc blocking reagent (Clone 24G2) was added to any cell suspension for 10 minutes at 4 C. Finally, extracellular staining was performed, and antibody mix was added to cell suspension for 20 minutes at 4 C. The following murine antibodies were used: anti-CD45-BV605, -BV650 or -PerCp-Cy5.5 (Clone 30-F11); anti-CD3e-PerCP-Cy5.5 or -APC (Clone 145-2C11); anti-CD45.2-BUV805 (Clone 104); anti-CD19-PE, -PerCP-Cy5.5 or -eFluor450 (Clone 1D3); anti-NK1.1-APC, -PE, -PECF594 or -BV650 (Clone PK136); anti-CD11b-BV421, -BV480, -BV786, -APCCy7, -FITC (Clone M1/70); anti-CD27-FITC, -APC-eFluor780 or PE-Cy7 (Clone LG.7F9); anti-CD4-AlexaFluor700 (Clone RM 4-5) or -FITC (Clone H129.19); anti-CD8-PE, BV480 or -BV570 (Clone 53-6.7); anti-iFNg-Alexa700 or -BV421 (Clone XMG1. To avoid non-specific tetramer binding, during MAIT staining cells were pre-incubated with the irrelevant unconjugated tetramer MR1 loaded with 6-FP (as described in Corbett et al., 2014; Rahimpour et al., 2015; Reantragoon et al., 2013) . Foxp3/Transcription Factor Staining Buffer Set (ThermoFisher) was used for intracellular staining of transcription factors and cytokines. Results are reported as frequency or as mean fluorescence intensity (MFI) normalized on isotype control or fluorescence minus one (FMO). Cells were analyzed on LSR Fortessa (BD Bioscience), for some experiments cells were analyzed on FACSymphony (BD Bioscience). Data were analyzed with FlowJo software (Treestar, Ashland, US).
PrimeFlow RNA Assay
PrimeFlow RNA Assay (ThermoFisher Scientific) was performed following manufacturer's instructions. Briefly, a single-cell suspension was obtained from dorsal skin of 3-MCA-treated mice and stained for surface antigens as described above. After fixation and permeabilization, il12a-AlexaFluor647-, il12b-AlexaFluor488-or actb-AlexaFluor647-conjugated target probes were added for hybridization, that was performed at 40 C for 2 hours. Signal amplification was achieved by adding PrimeFlow RNA Pre-Amp mix for 1.5 hours at 40 C and then PrimeFlow RNA Amp Mix for 1.5 hours at 40 C.
In vivo EdU-based proliferation assay EdU (5-ethynyl-2 0 -deoxyuridine) was administered i.p. (0.5mg/mice) to 3-MCA-treated mice, 24 hours before sacrifice once they reached the experimental endpoint (calculated tumor volume of 2000 mm 3 ). A single-cell suspension was obtained and surface antigen staining was performed. EdU staining was performed with Click-iT EdU AlexaFluor647 Flow Cytometry Assay Kit (ThermoFisher Scientific) following manufacturer's instructions.
Bone-marrow derived macrophages (BMDMs)
Mouse bone-marrow cells were isolated from femurs and tibiae of Csf3r +/+ mice and cultured at density of 1.5x10 6 cells/mL in RPMI-1640 medium supplemented with 10% Fetal Bovine Serum (FBS) 1% L-Glutammine, 1% Pen/Strept, with 20 ng/mL of murine GM-CSF or 25 ng/mL of murine M-CSF (both M-CSF and GM-CSF were purchased from Peprotech). Cells were washed with PBS and medium replaced at day 2 and 5. BMDMs were stimulated on day 7 with murine IFNg (20 mg/mL) or murine IL-4 (20 mg/mL), alone or in combination with murine G-CSF (50 ng/mL). After 24 hours cells were lysed with Trizol for further mRNA quantification. For co-culture experiments, GM-CSF-derived BMDMs were stimulated with GM-CSF (50 ng/mL), either alone or in combination with CpG (250 nM) (Invivogen, San Diego, US) or STING agonist cAIMP (1 mg/mL) (Invivogen). In indicated conditions, BMDMs were co-cultured with 3x10 5 FACS-sorted neutrophils for 24 hours. In transwell experiments neutrophils were added into the upper compartment of a Transwell permeable support with 0.4 mm pore (Corning, NY, US). After 24 hours medium was collected and IL-12p70 concentration was analyzed by ELISA.
Ex vivo functional assays
Tumor-infiltrating leukocytes were MACS-enriched using CD45 Microbeads (Miltenyi Biotec) according to manufacturer's instructions, obtaining a purity R 85%. Enriched cells were cultured in RPMI-1640 medium supplemented with 10% Fetal Bovine Serum (FBS) 1% L-Glutammine, 1% Pen/Strept and IFNg intracellular staining was performed upon 5 hours of treatment with Cell Stimulation Cocktail 1X (ThermoFisher), using Foxp3/Transcription Factor Staining Buffer Set (ThermoFisher). BD GolgiPlugTM (containing Brefeldin) was added 4 hours prior to intracellular staining.
Cytokines stimulation experiments were performed on MACS-enriched CD45 + Tumor-infiltrating leukocytes, that were previously depleted of CD11b + cells (CD11b Microbeads, Miltenyi Biotec). Enriched cells were stimulated with the indicated combinations of IL-2 (Proleukin, Novartis) (10ng/mL), recombinant murine IL-12 (Peprotech, London, UK) (20 ng/mL), human IL-18 (MBL, Woburn, US) (50 ng/mL) for 16 hours. BD GolgiPlugTM was added during the last 4 hours of stimulation. Intracellular staining was performed as indicated before using Foxp3/Transcription Factor Staining Buffer Set (ThermoFisher).
Purified splenic T cells from healthy Csf3r +/+ mice at a concentration of 3x10 6 cells/mL were stimulated with recombinant murine IL-12 (Peprotech, London, UK) (20 ng/mL) and/or human IL-18 (MBL, Woburn, US) (50 ng/mL) for 16 hours. BD GolgiPlugTM (containing Brefeldin) was added during the last 4 hours of stimulation.
In a second set of experiment, purified splenic T cells from healthy Csf3r +/+ mice were cultured with conditioned medium (CM) from BMDMs and neutrophils co-cultures at a concentration of 3x10 6 T cells/mL. Rat anti-iL-12p75 (Clone R2-9A5; Rat Isotype Control, Clone LTF-2) 20 mg/mL were added to the CM and incubated at 4 C for 30 minutes, before the incubation with T cells. Cells were incubated for 24 hours, and BD GolgiPlugTM was added during the last 4 hours of stimulation.
RNA purification
For qPCR experiments, total RNA was extracted using Trizol reagent (Invitrogen) following the manufacturer's recommendations. RNA was further purified using RNeasy Min-elute RNA isolation kit (QIAGEN, Hilden, Germany). For 3 0 mRNA sequencing experiments, RNA was purified with Maxwell 16 LEV SimplyRNA Cells Kit (Promega, Madison, US) using Maxwell 16 Instrument (Promega).
Quantitative PCR cDNA was synthesized using 2 mg of total RNA by reverse transcription using High Capacity cDNA archive kit (Applied Biosystems, Foster City, US) and quantitative real-time PCR was performed using the SybrGreen PCR Master Mix (Applied Biosystems) in a CFX96 TouchTM Real-Time PCR Detection System (Bio-Rad, Hercules, US). Data were analyzed with the D 2 CT method (Applied Biosystems, Real-Time PCR Applications Guide). Data were normalized based on the GAPDH expression determined in the same sample. Analysis of all samples was performed in duplicate. Primers were designed according to the published sequences and listed as follows:
Retnla (Fizz1): forward 5 0 -CCC TTC TCA TCT GCA TCT CC-3 0 , reverse 5 0 -CTG GAT TGG CAA GAA GTT CC-3 0 ; Chil3 (Ym1): forward 5 0 -TCT GGG TAC AAG ATC CCT GAA-3 0 , reverse 5 0 -TTT CTC CAG TGT AGC CAT CCT T-3 0 ; Ccl5: forward 5 0 -TGC AGA GGA CTC TGA GAC AGC-3 0 , reverse 5 0 -GAG TGG TGT CCG AGC CAT A-3 0 ; Nos2: forward 5 0 -GCC ACC AAC AAT GGC AAT A-3 0 , reverse 5 0 -CGT ACC GGA TGA GCT GTG AAT T-3 0 ; Ccl2: forward 5 0 -ATT GGG ATC ATC TTG CTG GT-3 0 , reverse 5 0 -CCT GCT GTT CAC AGT TGC C-3 0 ; Arg1: forward 5 0 -TTT TTC CAG CAG ACC AGC TT-3 0 , reverse 5 0 -AGA GAT TAT CGG AGC GCC TT-3 0 ; Tgfb1: forward 5 0 -CAA CCC AGG TCC TTC CTA AA-3 0 , reverse 5 0 -GGA GAG CCC TGG ATA CCA AC-3 0 ; Il27p28: forward 5 0 -AGC TCT TGA AGG CTC AGG G-3 0 , reverse 5 0 -GTG ACA GGA GAC CTT GGC TG-3 0 ; Ifng: forward 5 0 -TCA AGT GGC ATA GAT GTG GAA GAA-3 0 , reverse 5 0 -TGG CTC TGC AGG ATT TTC ATG-3 0 ; Il10: forward 5 0 -GGT TGC CAA GCC TTA TCG GA-3 0 , reverse 5 0 -ACC TGC TCC ACT GCC TTG CT-3 0 ; Stab1: forward 5 0 -CCC TCC TTC TGC TCT GTG TC-3 0 , reverse 5 0 -CAA ACT TGG TGT GGA TGT CG-3 0 ; Mrc1: forward 5 0 -TGG CAT GTC CTG GAA TGA T-3 0 , reverse 5 0 -CAG GTG TGG GCT CAG GTA GT-3 0 ; Msr1: forward 5 0 -TGC CCT CAT TGC TCT CTA CC-3 0 , reverse 5 0 -TTC ATT TCC CAA TTC AAA AGC TC-3 0 ; Il4ra: forward 5 0 -GTG GAG CCT GAA CTC GCA-3 0 , reverse 5 0 -AAG CAC GCA GAT CCA AAA TC-3 0 ; Marco: forward 5 0 -TTC TGT CGC ATG CTC GGT TA-3 0 , reverse 5 0 -CAG ATG TTC CCA GAG CCA CC-3 0 ; Met: forward 5 0 -TGT CCG ATA CTC GTC ACT GC-3 0 , reverse 5 0 -CAT TTT TAC GGA CCC AAC CA-3 0 ; Il1b: forward 5 0 -GGT CAA AGG TTT GGA AGC AG-3 0 , reverse 5 0 -TGT GAA ATG CCA CCT TTT GA-3 0 ; Ccl3: forward 5 0 -GTGGAATCTTCCGGCTGTAG-3 0 , reverse 5 0 -ACCATGACACTCTGCAACCA-3 0 ; Cxcl10: forward 5 0 -CCG TCA TTT TCT CCC TCA TCC-3 0 , reverse 5 0 -CCC TAT GGC TGC TTC ACT CTC A-3 0 ; Il23a: forward 5 0 -AGC ATT TAT GCT TCC AAA GC-3 0 , reverse 5 0 -GGA GGT CTC AAG TTC CTA CAT G-3 0 ; Ccr3: forward 5 0 -TGA AAC TGT GAT CTT GGG ACA-3 0 , reverse 5 0 -CAG CAT CAA CAA CAC GTT CC-3 0 ; Il1r5: forward 5 0 -GAT GCA TGT TTA GGC TTC CA-3 0 , reverse 5 0 -TCT TCT GCT GTC TGG AGC AA-3 0 ; Il1r7: forward 5 0 -AGA GTG CAG AGA GGC AAA CC-3 0 , reverse 5 0 -TGA AAC CCT CTT CCT CCA GA-3 0 ; Il12rb1: forward 5 0 -GCA GCC GAG TGA TGT ACA AG-3 0 , reverse 5 0 -GAG ACG CGA AAA TGA TGG AT-3 0 ; Il12rb2: forward 5 0 -AAC ACC AGA GGA AGA GCC TG-3 0 , reverse 5 0 -CGT CAC CTG ATA GTG GAG GA-3 0 ; Gapdh/GAPDH: forward 5 0 -GCA AAG TGG AGA TTG TTG CCA T-3 0 , reverse 5 0 -CCT TGA CTG TGC CGT TGA ATT T-3 0 .
3 0 -mRNA Sequencing Tumor-infiltrating CD4 + , CD8 + , UTC ab and gd T cells from Csf3r +/+ and Csf3r À/À sarcomas were FACS sorted (quadruplicates for Csf3r À/À and for Csf3r À/À mice), and RNA was prepared as described above.
Total RNA extracted from purified T cell subsets were subjected to Poly(A) mRNA sequencing. Libraries were constructed using the SMART Seq v4 Ultra Low Input RNA kit according to manufacturer's instruction (Illumina, San Diego, US). Sequencing was performed with the NextSeq 500 (Illumina). All libraries were sequenced in single-end mode (75bp length).
Single-cell RNA sequencing UTC ab sorted populations in Csf3r À/À and Csf3r +/+ mice were subjected to single-cell RNA sequencing analysis. Two biological replicates for each condition (Csf3r À/À and Csf3r +/+ ) were analyzed. Single cell suspensions of cells have been prepared by tissue mincing and enzyme digestion. FACS-sorted UTC ab were counted with an automatic cell counter (Countess II, Thermo Fisher). UTC ab were loaded into one channel of the Single Cell Chip A using the Single Cell 3 0 reagent kit v2 (10X Genomics) for gel bead emulsion generation. Following capture and lysis, cDNA was synthesized and amplified for 14 cycles following the manufacturer's protocol (10X Genomics). 50 ng of the amplified cDNA were then used for each sample to construct Illumina sequencing libraries. Sequencing was performed on the NextSeq500 Illumina sequencing platform following 10x Genomics instruction for reads generation. We recovered a total number of 15,137 cells from Csf3r +/+ and 17,388 cells from Csf3r À/À samples. An average sequencing depth of 20,000 reads/cell was recovered for each sample we processed. Cells with a null Cd3e unique molecular identifier (UMI) count were not considered further for the analysis, resulting in a total number of 31,623 cells (14,721 cells for Csf3r +/+ and 16,902 cells for Csf3r À/À samples).
Purification of murine leukocytes
Bone marrow neutrophils were MACS-enriched with Neutrophil Isolation Kit (Miltenyi Biotec) according to manufacturer's instructions for adoptive transfer experiments. Purity of neutrophils was > 98% as determined by flow cytometry.
For in vitro co-cultures experiments MACS-enriched neutrophils were stained for LiveDead-Fixable Dye eF780; anti-CD45-BV605; anti-CD11b-BV421; anti-Ly6G-PECF594 and sorted on a FACSAria cell sorter (BD Bioscience) to obtain a highly purified neutrophils population (purity > 99%).
Splenic T cells were MACS enriched with Pan T cell Isolation kit II (Miltenyi Biotec) according to manifacturer's instructions, for ex vivo stimulation with cytokines. Purity of the obtained CD3+ cells was > 99%. In some experiments, splenic T cells were MACS enriched and subsequently T cell subsets (CD4 + , CD8 + , UTC ab and gd T cells) were FACS-sorted. Resulting cells were processed for mRNA extraction.
For RNA expression analysis on neutrophils, macrophages, immature macrophages and monocytes, tumor-associated CD11b + cells were MACS-enriched (CD11b Microbeads, Miltenyi Biotec) according to manufacturer's instructions. CD11b+ cells represented more than 85% of resulting cell suspension. Next, neutrophils, macrophages, immature macrophages and monocytes were stained with LiveDead-Fixable Aqua, anti-CD45-BV605, anti-CD11b-BV786, anti-Ly6G-PECF594, anti-Ly6C-FITC, anti-F4/ 80-PECy7, anti-CD64-PE, anti-CD11c-AlexaFluor700 and sorted on a FACSAria cell sorter (BD Bioscience) to obtain high purity myeloid populations. Purity of each population was > 98%. Resulting cells were processed for mRNA extraction.
For RNaseq experiments on T cell subset populations, tumor cells were depleted of CD11b + cells and resulting cells were stained with LiveDead-Fixable Aqua, anti-CD45-BV605, anti-CD11b-APCCy7, anti-TCRb-BV711, anti-TCRgd-BV421, anti-CD4-AlexaFluor700 and anti-CD8-BV570 and sorted on a FACSAria cell sorter to obtain high purity T cell subset populations. Purity of each population was > 98%. Resulting cells were processed for mRNA extraction.
For single cell RNaseq experiments on UTC ab , tumor infiltrating leucocytes from Csf3r +/+ and Csf3r À/À mice were MACS-enriched (CD45 + TIL Microbeads), then CD11b + cells and CD4 + /CD8 + T cells were depleted. Cells were FACS-sorted as CD45 + /CD11b -/ TCRb + /TCRgd -/CD4 -/CD8cells. Resulting cells (purity < 99.9%) were further processed for single cell RNaseq.
For the in vivo cotransfer experiments, splenic T cells were first MACS-enriched with Pan T cells Isolation kit II; after negative selection of CD4 -/CD8 -T cells (CD4 + /CD8 + T cells Microbeads, Miltenyi Biotec) cells were stained with fluorophore-conjugated antibodies and DNT ab cells were FACS-sorted on a FACSAria as CD45 + /CD11b -/CD19 -/TCRb + /TCRgd -/CD4 -/CD8 -/MR1-OP-RU -/ CD1d-aGal/Cercells. Cell purity was < 99.0%.
Cytokine Measurement
Tumors or 3-MCA injection sites were homogenized in 1 mL PBS À/À containing protease inhibitors (Complete-EDTA-free; Roche) and PMSF (1mM). Tissue homogenates were centrifuged at 14000 rpm for 30 min at 4 C and supernatants were stored at À20 C for cytokine analysis. Murine IFNg, CCL2, CXCL1, CXCL2, CXCL12, M-CSF, G-CSF, TNFa, IL-22, IL-1b, IL-6, IL-12p70, VEGF, TGFb and IL-23p19 were measured in tissue homogenates by ELISA (R&D DuoSet ELISA Development System) according to manufacturer's instructions. Murine IL-18, IL-17A were measured in tissue homogenates by ProcartaPlex Assay (ThermoFisher) according to manufacturer's instructions.
Immunohistochemistry PFA-fixed, paraffin-embedded mouse tumor tissues were analyzed for each condition. Consecutive sections from the middle of the tissue were used for histological examination in each mouse. Paraffin-embedded tissue sections were mounted on Super-frost slides, dewaxed in xylene and rehydrated in ethanol. Endogenous peroxidase was blocked for 20 min in 90% ethanol containing 2% H 2 O 2 . Sections were then pretreated in a microwave oven (two cycles for 3 minutes each at 800 W, in 0.25 mM EDTA buffer). Unspecific sites were blocked with Rodent Block M (Biocare Medical) 30 minutes and tissues were incubated for two hours with affinity-purified Ig against CD31 (Clone MEC13.3; BD Bioscience) in PBS supplemented with BSA (1%) and NP40 (0.02%). Envision+ System HRP Labeled Polymer anti Rabbit (Dako), Rat on Mouse HRP-Polymer kit (Biocare Medical) was used as secondary antibody. For anti-human CD66b staining, paraffin embedded tissues were cut at 3 mm and put over night at 37 C. Then sections were dewaxed in xylene and rehydrated in ethanol. Antigen unmasking was performed in Decloaker Chamber in DIVA Buffer (Biocare Medical) (3 minutes at 125 C, 5 minutes at 90 C). Endogenous peroxidase was blocked with H 2 O 2 2% for 20 minutes. Unspecific binding sites were blocked with Background Sniper (Biocare Medical) for 15 minutes. Mouse anti-human CD66b (Clone G10F5; BD PharMingen, CA) or control antibody was diluted in Washing Buffer (PBS pH 7.00 + 0.05% Tween 20) and incubated in humid chamber 1h. MACH 1 HRP polymer (Biocare Medical) was used as secondary antibody. After washing, slides were developed with DAB (3,3 0 -diaminobenzidine) (Biocare Medical) and counterstained with Hematoxilyn. Tissues were dehydrated with ethanol, mounted with Eukitt and analyzed with an Olympus BX61 virtual slide scanning system. The number of CD66b + cells infiltrating the tumors was determined in whole tissue sections (magnification 20X) and mean values were employed to divide tumors in CD66b high and CD66b low .
QUANTIFICATION AND STATISTICAL ANALYSIS
Statistical analysis
For animal studies, sample size was defined on the basis of past experience on cancer models, to detect differences of 20% or greater between the groups (10% significance level and 80% power). Values were expressed as mean ± s.e.m. Wilcoxon matched-pairs signed-rank test was used to compare two groups for tumor incidence. Friedman test with Dunn's multiple comparison was used to compare tumor incidence for multiple group experiments. One-way ANOVA or Kruskal-Wallis test were used to compare multiple groups. Two-tailed multiple Student's t test was used to compare unmatched groups with Gaussian distribution. Two-tailed Mann-Whitney U-test was used to compare unmatched groups with non-Gaussian distribution. The Kaplan-Meier method was used for survival curve analysis, and the log-rank (Mantel-Cox) test was used to determine the statistical significance. p % 0.05 was considered significant. A ROUT test was applied to exclude outliers. Statistics were calculated with GraphPad Prism version 7, GraphPad Software.
3 0 -mRNA Sequencing analysis Raw reads were preprocessed for adaptor trimming and quality check was assessed using the FastQC tool (http://www. bioinformatics.babraham.ac.uk/projects/fastqc). Reads were aligned to the reference genome (Ensembl Mouse release GRC38) using the STAR (Dobin et al., 2013) algorithm. To minimize the variability among replicates, a coefficient of variation (CV) was calculated based on TMM (Trimmed Mean of M-Values) normalized expression values in each group. Genes exceeding 100% CV in at least one replicate's group were not considered for further differential expression analysis. Differential expression analysis was performed using the GLM approach implemented in the R/Bionconductor (Gentleman et al., 2004 ) edgeR (Robinson et al., 2010) package (p value % 0.001). Results of differential analysis are provided in Table S2 . The resulting gene lists were analyzed through the use of Ingenuity Pathways Analysis (IPA) (Krä mer et al., 2014) . Results of IPA analysis are provided in Table S3 .
Single cell RNA sequencing analysis Raw sequencing data in the format of bcl files were converted in fastq files and aligned to the mouse reference genome [http://cf. 10xgenomics.com/supp/cell-exp/refdata-cellranger-mm10-1.2.0.tar.gz] taking advantage of the Cell Ranger Pipeline version 2.1, provided by 10X Genomics. Raw digital gene expression matrix (unique molecular identifier (UMI) counts per gene per cell) were analyzed using the Seurat R package version 2.3.0 with default parameters. To assess the correlation between biological replicates in each condition we computed a Pearson correlation analysis using normalized gene expression matrices ( Figure S5L-M) . Based on high correlation between replicates, samples belonging to each condition were pooled together using the Cell Ranger aggregate option producing a unique raw digital gene expression matrix in Csf3r À/À and Csf3r +/+ conditions. Pooled data were imported into the Seurat pipeline and filtered applying the following thresholds: less than 200 or more than 3500 as unique expressed genes, more than 20000 as the number of UMIs and 10% as the percentage of mitochondrial genome content (for Csf3r +/+ condition) and less than 200 or more than 4000 as unique expressed genes, more than 20000 as the number of UMIs and 10% as the percentage of mitochondrial genome content (for Csf3r À/À condition). Cell cycle phases were predicted and corrected in each dataset using a Seurat function that scores each cell based on the expression of canonical marker genes for S and G2/M phases. The resulting dataset was normalized through a global-scaling method, converted by a scale factor (10,000 by default) and log-transformed using the ScaleData Seurat implemented function. A canonical correlation analysis was run in order to identify common sources of variation between the two datasets, using the RunCCA implemented function that stores into a single object the canonical correlation vectors. Finally an integrated analysis of the two datasets was performed choosing a number of 30 correlation components. The resulting data were subjected to clustering analysis using standard Seurat package procedures. A validation consistency procedure of the resolution (using the ValidateCluster function) allowed us to select 0.6 as the suitable resolution level. The total 12 identified clusters were visualized using t-distributed Stochastic Neighbor Embedding of the principal components (t-SNE) as implemented in Seurat.
Average gene expression matrices were retrieved for each cluster and a Spearman correlation analysis was performed, using the Picante R package version 1.6-2. Differential expression analysis among clusters (using the FindAllMarkers implemented function, with parameters only.pos = FALSE, min.pct = 0.2, thresh.use = 0.2) allowed us to select the top markers expressed at a higher level by each cluster.
Pathway enrichment analysis examining enriched processes in clusters was performed using Gene Set Variation Analysis (GSVA) software (Hä nzelmann et al., 2013) from Bioconductor (version 3.8). Mouse_AllPathways_November_01_2018_symbol.gmt from [http://download.baderlab.org/EM_Genesets/current_release/] was used to identify enriched cellular pathways in GSVA.
Single-cell trajectory analysis
Monocle (Qiu et al., 2017; Trapnell et al., 2014) was used to investigate transcriptional and functional trajectories concerning the twelve clusters identified with Seurat (see Cell clustering, differential expression and pathway analysis paragraph). Using the reversed graph embedding approach, Monocle learns the kinetics of gene expression and places each cell along an inferred trajectory. The data, in the format of raw data, together with clusters information deriving from Seurat, were loaded into a Monocle object. Normalization and dimensionality reduction were performed using default parameters. The trajectory was designed using the plot_cell_trajectory command. Cells were ordered along an artificial trajectory based on gene expression changes among clusters. Genes that underwent a significant change along pseudotime (q-value < 0.05) were visualized by a heatmap using plot_pseudotime_heatmap. The trend of Klra1, Klra6, Klra7 and Klrd1 gene expression was depicted by individual graphs using the plot_genes_in_pseudotime function.
Public gene expression data analysis
Publicly available RNA sequencing data were downloaded from the Cancer Genome Atlas database (TCGA) through the Firebrowse repository (http://firebrowse.org/; release 01/28/2016), for Sarcoma dataset (SARC) and from Xena Browser (https://xenabrowser. net/) for Melanoma dataset (SKCM).
The sarcoma dataset included a total of 261 tumor samples, classified in the following subtypes: dedifferentiated liposarcoma (n = 58), desmoid tumor (n = 2), giant cell sarcoma (n = 1), leiomyosarcoma (lms, n = 104), malignant peripheral nerve sarcoma (mpnst, n = 10), myxofibrosarcoma (n = 25), synovial sarcoma (n = 10), undifferentiated sarcoma (ups, n = 51). Sarcoma histotypes with a total number of samples < 10 were excluded from further analysis. The Melanoma dataset included a total of 474 patients. RSEM (RNASeq by Expectation-Maximization) expression values were retrieved and log-transformed. For colorectal cancer (CRC) cohort we used a microarray dataset (GEO: GSE24551) including a total of 160 samples. For ovarian cancer we used a microarray dataset (GEO: GSE32062) including a total of 270 samples, from which we selected the high grade cohort (128 samples). For both datasets we used respectively Robust Multi-array Average (RMA) and Normalized Signal Intensity (NSI) gene expression values as provided by GEO.
Survival analysis was performed with GraphPad Prism TM using the Kaplan-Meier (KM) approach and applying the Log-rank (Mantel-Cox) test to estimate survival curves comparison. For CSF3R survival analysis, the median gene expression value was used to classify tumor samples into CSF3R low and CSF3R high gene expression groups. A signature of 31 neutrophil-related genes was retrieved from Bindea et al. (Bindea et al., 2013) (Table S6 ). This neutrophil-specific gene signature was based on previous microarray datasets of gene expression in resting and activated human peripheral blood leukocyte subsets (Chtanova et al., 2005) . In particular, the signature is composed of genes with higher expression in resting and LPS-activated neutrophils compared to any other leukocyte subset. Of note, CSF3R was included in the neutrophil signature and, in the TCGA dataset of UPS patients, a significant correlation was observed between CSF3R expression and 28 out of 30 genes present in the neutrophil signature (not shown). Type 1 immune response gene signature was designed by including factors known to be upstream or downstream of IFNG signaling pathway (genes listed in Table S6 ) (Ayers et al., 2017; Ikeda et al., 2002; Murphy et al., 2000; Swain et al., 2012) . Their expression correlated with IFNG (p < 0.005, not shown). For both signatures, RSEM or normalized signal values were converted into z-score applying the following transformation: z-score = (X -average(X))/stdev(X), where X represents gene expression values. The average and standard deviation were calculated considering the expression of X across all tumor samples, as previously described (Chao et al., 2016) . Finally, the median z-score value was considered as the threshold to define Low and High expression groups. Figures 1A and 1B , n = 10 mice per group; Figure 1C , n = 20 (Csf3r +/+ ), n = 8 (Csf3r À/À ), n = 12 (Csf3r À/À + Nf). Figures 1A and 1B , one representative experiments out of twenty performed; Figure 1C , pooled data of two independent experiments performed. Figure 2A , n = 9 mice per group; Figures 2B and 2C , n = 8 (Csf3r +/+ isotype), n = 9 (Csf3r +/+ anti-CD115), n = 9 (Csf3r À/À isotype) or n = 10 (Csf3r À/À anti-CD115) mice per group, Figure 2D , n = 5 (Csf3r +/+ ), n = 5 (Csf3r À/À ), n = 4 (Csf3r À/À + Nf); Figure 2E , n = 10 (Csf3r +/+ ), n = 10 (Csf3r À/À ), n = 4 (Csf3r À/À + Nf) Figure 2F , n = 9 mice per group; Figures 2A-2F , one experiment performed. Figure 3A , n = 12 (Csf3r +/+ ) or n = 18 (Csf3r À/À ) mice; Figure 3C , n = 16 (Csf3r +/+ ) or n = 21 (Csf3r À/À ) mice; Figure 3D , n = 5 (Csf3r +/+ ), n = 14 (Csf3r À/À ), n = 5 (Csf3r À/À +neutrophils); Figure 3E , n = 11 (Csf3r +/+ ), n = 14 (Csf3r À/À ), n = 14 (Csf3r À/À + neutrophils) mice; Figure 3F , n = 9 (Csf3r +/+ ), n = 20 (Csf3r À/À ) mice per group, Figure 3G , n = 5 (Csf3r +/+ ), n = 14 (Csf3r À/À ), n = 5 (Csf3r À/À + NF) mice per group. Pooled data of two ( Figures 3A, 3C , 3E, and 3F) experiments are shown. Figures 3D and 3G , one experiment performed. Figure 4A , n = 4 mice per group; Figures 4B and 4C , n = 4 mice per group; Figure 4D , n = 3 mice per group; Figure 4E , n = 6 (Csf3r +/+ isotype), n = 7 (Csf3r +/+ anti-iL-12p70), n = 5 (Csf3r À/À isotype) or n = 4 (Csf3r À/À anti-iL-12p70) mice per group; Figure 4G , n = 5 (Mf), n = 5 (Nf), n = 8 (Mf+Nf), n = 3 (Mf+Nf Transwell); Figure 4H , n = 4 mice per group; Figure 4I , n = 10 mice per group. Figures 4A-4F , one experiment performed. Pooled data of two (Figures 4G and 4H) or three ( Figure 4I 
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Data availability and accession
The accession number for the bulk RNA-sequencing data reported in this paper is Gene Expression Omnibus (GEO) (https://www. ncbi.nlm.nih.gov/geo/): GSE109031. The accession number for the single cell RNA-sequencing data reported in this paper is Gene Expression Omnibus (GEO): GSE123508.
The authors declare that all other data supporting the findings of this study are available within the article and its supplementary information files.
Reagent availability
Reagents used in the present study are described in the Key Resources Table. (E-F) 3x10 6 neutrophils were i.v. transferred once a week starting from the first day the tumor was palpable. (G-I) 3x10 6 neutrophils were i.v. transferred at days À1, 0, 1 and 9 with respect to 3-MCA administration. (B) n = 16 (Csf3r +/+ ) or n = 21 (Csf3r À/À ) mice. (E-F) n = 5 (Csf3r +/+ ), n = 14 (Csf3r À/À ) or n = 5 (Csf3r À/À + neutrophils). (G-I) n = 6 (Csf3r +/+ ), n = 7 (Csf3r À/À ) or n = 7 (Csf3r À/À + Nf) mice. (J) n = 6 (Csf3r +/+ ), n = 7 (Csf3r À/À ) mice. (L), (N) n = 7 mice per group. 
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